(2S,3R,4S,5R)-2-(((3R,4S,5R,6R)-4,5-Diacetoxy-6-methoxytetrahydro-2H-pyran-3-yl)oxy)tetrahydro-2H-pyran-3,4,5-triyl triacetate

Catalog No. :
ACIIEM253
CAS No. :
68977-81-1
Molecular Formula :
C21H30O14
Molecular Weight :
506.46

IUPAC Name:(2S,3R,4S,5R)-2-(((3R,4S,5R,6R)-4,5-diacetoxy-6-methoxytetrahydro-2H-pyran-3-yl)oxy)tetrahydro-2H-pyran-3,4,5-triyl triacetate

(2S,3R,4S,5R)-2-(((3R,4S,5R,6R)-4,5-Diacetoxy-6-methoxytetrahydro-2H-pyran-3-yl)oxy)tetrahydro-2H-pyran-3,4,5-triyl triacetate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name(2S,3R,4S,5R)-2-(((3R,4S,5R,6R)-4,5-Diacetoxy-6-methoxytetrahydro-2H-pyran-3-yl)oxy)tetrahydro-2H-pyran-3,4,5-triyl triacetate
IUPAC Name(2S,3R,4S,5R)-2-(((3R,4S,5R,6R)-4,5-diacetoxy-6-methoxytetrahydro-2H-pyran-3-yl)oxy)tetrahydro-2H-pyran-3,4,5-triyl triacetate
Molecular FormulaC21H30O14
Molecular Weight506.46
SMILESCO[C@@H]1OC[C@@H](O[C@@H]2OC[C@@H](OC(C)=O)[C@H](OC(C)=O)[C@H]2OC(C)=O)[C@H](OC(C)=O)[C@H]1OC(C)=O
InChI KeyUFXGTTMJHOCPOR-HXAVOKFQSA-N
Synonymβ-D-Xylopyranoside, methyl 4-O-(2,3,4-tri-O-acetyl-β-D-xylopyranosyl)-, 2,3-diacetate;Methyl β-xylobioside penta-O-acetate
CAS No.68977-81-1

Synthetic Route by SureRoute

1. ACIIEM253 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACCZIU451 route compound structure diagram
    ACCZIU451563-67-7 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACIIEM253 route product structure diagram
    ACIIEM25368977-81-1
Inquiry

2. ACIIEM253 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACIIEM253 route product structure diagram
    ACIIEM25368977-81-1
Inquiry

Comments (0)